Venetoclax in Chronic Lymphocytic Leukemia
2 Views
administrator
07/08/23
The panelists, William G. Wierda, MD, PhD; Shuo Ma, MD, PhD; Thomas J. Kipps, MD, PhD; and Alessandra Ferrajoli, MD, introduce venetoclax, an investigational drug currently being assessed in the treatment of patients with chronic lymphocytic leukemia.
-
Category
Show more
Facebook Comments
No comments found